Risk Factors Associated with Severe Disease in COVID-19

Objective & Hypothesis:Aim: The aim of this study was to determine the characteristics and risk factors associated with severe disease in COVID-19.

📊

Key Findings & Data:Materials and Methods: A total of 186 adult patients (97 female) hospitalized with a diagnosis of COVID-19 (laboratory-confirmed cases, SARS-CoV-2-RNA detected with the molecular method) between March 2020-May 2020 were included in the study.

💡

Conclusion & Impact:Clinicians should consider these potential risk factors for progression to severe disease when treating COVID-19 patients.

🔬Design:Research Article

📍Scope:2020 Verileri

⚙️Variables:COVID-19 · pandemi · risk faktörü

Abstract

Aim: The aim of this study was to determine the characteristics and risk factors associated with severe disease in COVID-19. Materials and Methods: A total of 186 adult patients (97 female) hospitalized with a diagnosis of COVID-19 (laboratory-confirmed cases, SARS-CoV-2-RNA detected with the molecular method) between March 2020-May 2020 were included in the study. The possible risk factors evaluated were age, gender, comorbidities, smoking, symptoms, and laboratory parameters at the time of admission to the hospital. Results: The patients comprised 97 (52.2%) females, evaluated as severe COVID-19 in 43 (23.1%) cases and non-severe COVID-19 in 143 (76.9%) cases. Multivariate logistic regression analysis identified risk factors for severe COVID-19 to be age >65 years (odds ratio (OR)=5.289, 95% confidence interval (CI):1.680-16.651, p:0.004), and elevated levels of LDH (OR=8.521, 95% CI:2.445-29.702, p:0.001), ferritin (OR=7.436, 95% CI:2.171-25.468, p:0.001), D-dimer (OR=10.076, 95% CI: 2.758-36.813, p65 years, and elevated LDH, ferritin, D-dimer, CK-MB, and troponin levels are independent risk factors. Clinicians should consider these potential risk factors for progression to severe disease when treating COVID-19 patients.

Özet

Amaç: Çalışmamızın amacı COVID-19’da şiddetli hastalık ile ilişkili özellikler ve risk faktörlerinin belirlenmesidir. Gereç ve Yöntem: Mart 2020-Mayıs 2020 tarihleri arasında COVID-19 (moleküler yöntemle SARS-CoV-2-RNA tespit edilen olgular) tanısı ile hastaneye yatırılan toplam 186 yetişkin hasta (97 kadın) çalışmaya dahil edildi. Olası risk faktörleri olarak yaş, cinsiyet, komorbidite, sigara kullanımı, semptomlar ve yatış sırasındaki bazı laboratuvar parametreleri irdelendi. Bulgular: Hastaların 97’si (%52,2) kadın olup, 43 (%23,1) olgu şiddetli COVID-19 ve 143 (%76,9) olgu şiddetli olmayan COVID-19 olarak değerlendirildi. Çoklu değişkenli lojistik regresyon analizinde; 65 yaş üzeri (odds oranı (OR)=5.289, %95 güven aralığı (CI) 1.680-16.651, p=0.004), artmış LDH (OR=8.521, 95% CI:2.445-29.702, p:0.001), ferritin (OR=7.436, 95% CI:2.171-25.468, p:0.001), D-dimer (OR=10.076, 95% CI: 2.758-36.813, p

Keywords

COVID-19 pandemi risk faktörü şiddetli hastalık pandemic risk factor severe disease

🔖

Cite This Article

ÇÖLKESEN, F., EROĞLU, E., AYDIN, T., TARAKÇI, A., ARMAĞAN, Ş. Ö., ÇIĞCI, M., KACAR, F. (2022). Risk Factors Associated with Severe Disease in COVID-19. Journal of Contemporary Medicine, Cilt: 12 - Sayı: 2, 255–260. https://ajindex.com/articles/774852

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (12)

Lai CC, Wang CY, Wang YH, et al. Global epidemiology of coronavirus disease 2019 (COVID19): disease incidence, daily cumulative index, mortality, and their association with country health care resources and economic status. Int J Antimicrob Agents 2020 Mar 19
105946. Reference2. Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a Report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020
Cai H, Chen Y, Chen Z, et al. Handbook of COVID-19 prevention and treatment. 1st ed. Liang T, editor. China: The First Affiliated Hospital, Zhejiang University School of Medicine 2020. p. 1-84. Reference4. Ou M, Zhu J, Ji P, et al. Risk factors of severe cases with COVID-19: a meta-analysis. Epidemiol Infect 2020 Aug 12
e175. Reference5. National Institutes of Health. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Available from:https://covid19treatmentguidelines.nih.gov Reference6. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020
395 (10223):497–506. 6. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020
395 (10223):497–506. Reference7. İlgili Ö, Kutsal YG. Impact Of Covid-19 Among The Elderly Population. Turkish Journal of Geriatrics 2020
23(4):419-23. Reference8. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020
395(10229): 1054-62. Reference9. Zhang JJ, Cao YY, Tan G, et al. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients. Allergy 2021
Ebinger JE, Achamallah N, Ji H, et al. Pre-existing traits associated with Covid-19 illness severity. PLoS One 2020
15(7):e0236240. Reference11. Castle SC, Uyemura K, Fulop T, Makinodan T. Host resistance and immune responses in advanced age. Clinics in geriatric medicine 2007
23(3),463-79. Reference12. Cesari M, Araujo de Carvalho I, Amuthavalli Thiyagarajan J, et al. Evidence for the domains supporting the construct of intrinsic capacity. The Journals of Gerontology. Series A 2018
73(12),1653-60. Reference13. Phan LT, Nguyen TV, Luong QC, et al. Importation and human-to-human transmis